Givosiran
Oligonucleotide
Overview
Givosiran is a oligonucleotide active pharmaceutical ingredient (ChEMBL CHEMBL4297760).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Givosiran expires 3 Oct 2034 and exclusivity 20 Nov 2026. Generic API sourcing typically opens up once these lapse.
Verified Supplier Partner
Do you supply Givosiran? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.